Issue 3/2013 |
Focus on Meningiomas |
Soffietti R
Editorial
PDF |
p. 93 |
Grisold W, Soffietti R
Editorial to Special Issue
PDF Figures |
p. 94 |
Wöhrer A
Epidemiology of Meningioma
PDF Summary |
pp. 95-96 |
Lefranc F
Incidental Meningiomas
PDF Summary |
pp. 97-99 |
Roelcke U
Prognostic Factors in Meningioma
PDF Summary |
pp. 100-101 |
Horowitz PM, Beroukhim R, Dunn IF, Brastianos PK
Genomic Characterization of Meningiomas
PDF Summary |
pp. 102-104 |
Ketter R, Oertel J, Linsler S, Urbschat S
Recurrence and Progression in Meningiomas: The Clonal Cytogenetic Evolution of a Benign Human Tumour
PDF Summary |
pp. 105-111 |
Millesi M, Kueß M, Widhalm G, Knosp E
Current Surgical Strategies in the Treatment of Intracranial Meningiomas
PDF Summary Figures |
pp. 112-117 |
Perneczky G, Loyoddin M, Schappelwein H, Sherif C
Spinal Meningiomas: A Comprehensive Overview and Own Experience
PDF Summary Figures |
pp. 118-121 |
Asklund T, Henriksson R
Radiotherapy and Meningioma
PDF Summary Figures |
pp. 122-127 |
Marosi C
Drug Therapy for Recurrent, Progressive, Atypical, and Malignant Meningiomas
PDF Summary |
pp. 128-131 |
Simo M, Izquierdo C, Bruna J
Systemic Treatment of Recurrent Meningioma
PDF Summary |
pp. 132-138 |
Rössler K, Coras R, Blümcke I
Case Report:Long-Term Epilepsy-Associated Giant Lobar Collision Tumour
PDF Figures |
pp. 139-140 |
Zijdewind J, Wesseling P, de Witt Hamer PC, Reijneveld J
Case Report: Primary Leptomeningeal Melanoma in a Patient with Neurocutaneous Melanosis
PDF Figures |
pp. 141-142 |
Zwinkels H
Specialized Nursing Roles: Pros and Cons
PDF |
pp. 143-144 |
Oliver K
Searching for an Anchorage in an “Unmoored State” How Can Patients with Brain Metastases Be Helped by Brain Tumour Patient Advocacy and Support Organisations?
PDF |
pp. 145-147 |
|
p. 148 |
Florian IA
Congress Report: 3rd National Conference of Neuro-Oncology with International Participation
PDF Figures |
p. 150 |
Berghoff A, Preusser M
Congress Report: Brain Metastases: A Meeting Report from the Annual Meeting of the American Society of Clinical Oncology 2013
Disclaimer: This report reflects the impression of the authors and does not necessarily reflect the opinion of the EANO.
PDF |
pp. 151-154 |
Abacioglu U
Interview with Dr Michael Weller (Zurich) about the Phase-III EGFRvIII Vaccine Trial on Newly Diagnosed EGFRvIII-Positive Glioblastoma
PDF Figures |
pp. 155-156 |
Weller M
Hotspots in Neuro-Oncology
PDF |
pp. 157-158 |